Saturna Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,410
| Closed | -$972K | – | 160 |
|
|
2025
Q1 | $972K | Sell |
13,410
-10,830
| -45% | -$775K | 0.01% | 98 |
|
|
2024
Q4 | $1.79M | Sell |
24,240
-294
| -1% | -$20.6K | 0.02% | 80 |
|
|
2024
Q3 | $1.62M | Buy |
24,534
+1,618
| +7% | +$118K | 0.02% | 87 |
|
|
2024
Q2 | $2.12M | Buy |
22,916
+305
| +1% | +$27K | 0.03% | 79 |
|
|
2024
Q1 | $2.16M | Buy |
22,611
+1,109
| +5% | +$93.2K | 0.03% | 84 |
|
|
2023
Q4 | $1.64M | Sell |
21,502
-120
| -0.6% | -$8.35K | 0.03% | 94 |
|
|
2023
Q3 | $1.5M | Sell |
21,622
-395
| -2% | -$31.7K | 0.03% | 94 |
|
|
2023
Q2 | $2.08M | Buy |
22,017
+2,280
| +12% | +$198K | 0.04% | 80 |
|
|
2023
Q1 | $1.63M | Buy |
19,737
+1,132
| +6% | +$89K | 0.03% | 88 |
|
|
2022
Q4 | $1.39M | Sell |
18,605
-1,530
| -8% | -$118K | 0.03% | 91 |
|
|
2022
Q3 | $1.66M | Buy |
20,135
+50
| +0.2% | +$4.81K | 0.04% | 80 |
|
|
2022
Q2 | $1.91M | Buy |
20,085
+350
| +2% | +$36.2K | 0.05% | 77 |
|
|
2022
Q1 | $2.32M | Sell |
19,735
-3,780
| -16% | -$424K | 0.05% | 80 |
|
|
2021
Q4 | $3.05M | Buy |
23,515
+300
| +1% | +$35K | 0.05% | 76 |
|
|
2021
Q3 | $2.63M | Sell |
23,215
-280
| -1% | -$32K | 0.05% | 77 |
|
|
2021
Q2 | $2.43M | Buy |
23,495
+400
| +2% | +$37.7K | 0.05% | 77 |
|
|
2021
Q1 | $1.93M | Buy |
23,095
+420
| +2% | +$35.5K | 0.04% | 84 |
|
|
2020
Q4 | $2.07M | Buy |
22,675
+500
| +2% | +$41.5K | 0.05% | 84 |
|
|
2020
Q3 | $1.77M | Buy |
22,175
+200
| +0.9% | +$15.6K | 0.05% | 83 |
|
|
2020
Q2 | $1.52M | Hold |
21,975
| – | – | 0.04% | 86 |
|
|
2020
Q1 | $1.57M | Buy |
21,975
+750
| +4% | +$54.1K | 0.05% | 86 |
|
|
2019
Q4 | $1.65M | Hold |
21,225
| – | – | 0.04% | 95 |
|
|
2019
Q3 | $1.56M | Buy |
21,225
+150
| +0.7% | +$10.5K | 0.05% | 96 |
|
|
2019
Q2 | $1.3M | Hold |
21,075
| – | – | 0.04% | 101 |
|
|
2019
Q1 | $1.34M | Hold |
21,075
| – | – | 0.04% | 93 |
|
|
2018
Q4 | $1.08M | Hold |
21,075
| – | – | 0.04% | 94 |
|
|
2018
Q3 | $1.22M | Sell |
21,075
-450
| -2% | -$22K | 0.04% | 98 |
|
|
2018
Q2 | $1.04M | Hold |
21,525
| – | – | 0.03% | 101 |
|
|
2018
Q1 | $1M | Sell |
21,525
-7,500
| -26% | -$326K | 0.03% | 102 |
|
|
2017
Q4 | $1.09M | Buy |
29,025
+600
| +2% | +$22K | 0.03% | 103 |
|
|
2017
Q3 | $996K | Buy |
28,425
+825
| +3% | +$31.5K | 0.03% | 106 |
|
|
2017
Q2 | $1.09M | Hold |
27,600
| – | – | 0.04% | 99 |
|
|
2017
Q1 | $865K | Hold |
27,600
| – | – | 0.03% | 105 |
|
|
2016
Q4 | $862K | Buy |
27,600
+6,600
| +31% | +$214K | 0.03% | 109 |
|
|
2016
Q3 | $844K | Buy |
+21,000
| New | +$791K | 0.03% | 111 |
|
Other funds holding EW
Saturna Capital's EW Position: Q2 2025 in Review
Saturna Capital sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 13,410 shares — an estimated $972K sold.
Saturna Capital first reported a position in EW in Q3 2016 and held it in 35 quarters. The position peaked at $3.05M in Q4 2021. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Saturna Capital reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Saturna Capital sold 13,410 Edwards Lifesciences shares in Q2 2025, an estimated $972K.
- Saturna Capital first reported a position in Edwards Lifesciences in Q3 2016 and held it in 35 quarters.
- Saturna Capital's Edwards Lifesciences position peaked at $3.05M in Q4 2021.
- 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Saturna Capital's 13F filing for Q2 2025, filed 12 Aug 2025.